This is stated in the joint article of the Director of the European Regional Office of the World Health Organization (WHO) Hans Klaj and the representative of the organization in Russia Meliti Vuynovich
"An example for future generations" was called the work of Russian doctors in the fight against coronavirus infection. This is stated in the joint article of the Director of the European Regional Office of the World Health Organization (WHO) Hans Klaj and the representative of the organization in Russia Meliti Vuynovich. Attention on published material turned to TASS.
"In the Russian Federation, we witnessed the heroic dedication, the professionalism and dedication of all health workers in the fight against COVID-19 ... The performance of their professional debt is an excellent example for future generations," the article Hans Kleva and Meliti Vuynovich.In addition, the authors of the publication highly appreciated the participation of Russian citizens in volunteer movement. Volunteers helped make the means of individual protection against infection, delivered products and medicines, took care of animals and performed many other responsibilities that people who were forced to be at home.
In Russia, from the first numbers of December, the vaccination of citizens began from risk groups, which includes doctors, military, police officers, teachers and educators, social workers. In the capital, trading, industry, services, transport, culture and journalists can also make vaccination. Students of Moscow universities and colleges who already have 18 years can also be hurt.
The first Russian vaccine "Satellite V" was registered on August 11. She was developed in the center of them. Gamalei. It confirmed its effectiveness by 91.4%, against severe cases of the disease - 100%. At the end of 2020, more than 2 million doses of the drug were manufactured. In the near future, 1 million doses will go to civil turnover. Scientists of the Center plan to launch the Light Vaccine version.
In addition, in Russia they created and registered the second vaccine - "Vector". At the moment, it passes the post-registration tests on volunteers of 18-60 years and a group of participants over 60 years.